Showing 2011-2020 of 3411 results for "".
EHR User Series—Part IV
https://practicaldermatology.com/topics/practice-management/ehr-user-seriespart-iv/21494/The final entry in a Q&A series with clinicians about their experience and broader impressions of EHRs in dermatology.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21521/Effective Speechmaking for Physicians
https://practicaldermatology.com/topics/practice-management/effective-speechmaking-for-physicians/21666/Dermatologists can utilize these tips to exude confidence, make a good first impression, and connect with any audience.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21750/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21777/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21941/Topical Rejuvenation Options for the Hyperpigmentation Patient
https://practicaldermatology.com/topics/general-topics/PD0609_03-php/22812/Appropriate rejuvenation regimens can actually correct hyperpigmentation and not make it worse.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0609_05-php/22814/Cosmetic Dermatology: Ensuring Success at Any Level
https://practicaldermatology.com/topics/general-topics/PD0409_02-php/22840/In practice and perspective, a balanced approach to cosmetic and medical affairs coupled with a strong team ensures effective implementation of cosmetic services.TNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.